In the summer of 1958 we observed that the results of serum glutamic-oxaloacetic transaminase (SGO -T) determinations by the spectrophotometric method of Karmen, Wroblewski, and LaDue (1955) appeared to be appreciably higher than during previous months. This suspicion was confirmed when the sera from three out of six healthy young adults were found to give SGO-T values greater than 40 units per ml., the upper limit of the normal range found in these laboratories by Pryse-Davies and Wilkinson (1958) . No In each case the transaminase activity is proportional to the rate of oxidation of reduced diphosphopyridine nucleotide (D.P.N.H.), the destruction of which is followed by observing the fall in optical density at 340 mu.
Impurity of Malic Dehydrogenase
The increase in SGO-T figures appeared to coincide with the introduction of a new batch of malic dehydrogenase (M.D.H. 1), but this enzyme did not effect transamination in the absence of serum and hence did not appear to be contaminated with a transaminase. The explanation of the anomaly, however, was obtained from studies with pyridoxal 5-phosphate which is known to function as a coenzyme in transamination reactions (Lichstein, Gunsalus, and Umbreit, 1945 These results suggested that pyridoxal 5-phosphate activated a glutamic-oxaloacetic apo-transaminase contaminating M.D.H. 1. Malic dehydrogenase is obtained commercially from heart muscle, a tissue rich in glutamicoxaloacetic transaminase, and it is likely that the end-product might be contaminated by the corresponding apo-transaminase, the coenzyme having been removed during purification. The presence of the contaminating apo-transaminase would remain undetected until the addition of pyridoxal 5-phosphate.
Adding pyridoxal 5-phosphate to lactic dehydrogenase (the enzyme used for SGP-T determination) showed that it too contained glutamic-oxaloacetic apo-transaminase but in a much smaller amount than M.D.H. 1. Lactic dehydrogenase is prepared from skeletal muscle, a tissue which contains glutamic-oxaloacetic transaminase but does not contain a significant amount of glutamic-pyruvic transaminase. Contamination with glutamic-oxaloacetic apotransaminase and freedom from contamination SERUM GLUTAMIC-OXALOACETIC TRANSAMINASE DETERMINATION with glutamic-pyruvic apo-transaminase is therefore to be expected, and this would explain our inability to demonstrate an effect of pyridoxal 5-phosphate on the glutamic-pyruvic transaminase system.
A second sample of malic dehydrogenase (M.D.H. 2) obtained from a different supplier showed no transaminase activity when pyridoxal 5-phosphate was added in 10 times the concentration previously found to activate M.D.H. 1. Parallel SGO-T determinations were made on a number of sera using both batches of malic dehydrogenase, and the results were Experiments with pyridoxal 5-phosphate indicated that the discrepancy between the SGO-T values obtained using the malic dehydrogenases from the different suppliers could be accounted for by assuming a serum pyridoxal 5-phosphate level of between 10 and 100 jug. per 100 ml. Conclusions It is recommended that batches of malic dehydrogenase intended for SGO-T determination should not only be tested for possible transaminase contamination using a blank containing malic dehydrogenase and omitting serum, but also for apo-transaminase content using a blank containing pyridoxal 5-phosphate in place of serum. Alternatively new supplies of malic dehydrogenase may be compared with a batch known to give satisfactory results by carrying out parallel SGO-T determinations on a number of different sera, the method used during the course of the study by Pryse-Davies and Wilkinson (1958) .
It is further suggested that the activation by pyridoxal 5-phosphate of the glutamicoxaloacetic apo-transaminase contaminating certain preparations of malic dehydrogenase might form the basis of a method for the determination of pyridoxal. Summary Erroneously high serum glutamic-oxaloacetic transaminase (SGO-T) levels determined by the spectrophotometric method were found to be due to the presence of an apo-transaminase in the malic dehydrogenase used.
It is recommended that each batch of malic dehydrogenase should be tested for the presence of this apo-transaminase by carrying out blank determinations in which serum is replaced by pyridoxal 5-phosphate.
The possibility of using samples of malic dehydrogenase containing apo-transaminase as a means of determining pyridoxal is suggested.
